Skip to main content

Find Clinical Trials

Home
Conditions
Gastrointestinal Neoplasms

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

9,184 public trials 2,031 recruiting studies

Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Not Yet Recruiting

QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal Cancer

NCT07025239

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

AK112 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI as Second-line Treatment of MSS/pMMR Metastatic Colorectal Cancer

NCT07021950

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Tislelizumab Combined With Chemotherapy for the Perioperative Treatment of Esophageal Squamous Carcinoma

NCT07019181

Conditions: Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Neoadjuvant Pembrolizumab With a Watch-and-wait Strategy for dMMR/MSI-H Localized Colon Cancer: PREMICES Study.

NCT06646445

Conditions: Colon Cancer, Colonic Diseases, Colonic Neoplasms, +14 more
Locations: Institut Sainte Catherine Avignon, France

CHU Besançon Besançon, France

IHFB Cognacq Jay Levallois-Perret, France

Centre Leon Berard Lyon, France

View Trial Details

Not Yet Recruiting

Neoadjuvant Nab-Paclitaxel Plus Oxaliplatin, S-1, and Sintilimab in Early-Onset Resectable Gastric Cancer

NCT07018063

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric (Cardia, Body) Cancer, +8 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

QL1706 Plus Bevacizumab for Unresectable or Metastatic MSI-H/dMMR CRC

NCT07009145

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +11 more
Locations: The First Affiliated Hospital of Shandong First Medical University Jinan, Shandong, China

View Trial Details

Not Yet Recruiting

Iparomlimab/Tuvonralimab Combined With Bevacizumab and CAPEOX as Conversion Therapy for Colorectal Cancer Liver Metastasis

NCT07007728

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Peking University Cancer Hospital & Institute Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Continuous or Intermittent Cetuximab Plus FOLFIRI as First-line Treatment in RAS/BRAF Wild-type mCRC Patients

NCT07004413

Conditions: Colonic Diseases, Colorectal Cancer Metastatic, Colorectal Neoplasms, +9 more
Locations: Charite University, Berlin Berlin, Germany

View Trial Details

Not Yet Recruiting

Rimegepant Combined With PD-1 in Liver Metastasis Colorectal Cancer Patients

NCT06999252

Conditions: Colon Cancer, Colonic Diseases, Colonic Neoplasms, +9 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Radiation-induced Toxicity of the Heart

NCT06986291

Conditions: Breast Cancer Female, Breast Diseases, Breast Neoplasms, +30 more
Locations: University of Technology, University Hospital Carl Gustav Carus, Department of Radiation Therapy and Radiation Oncology Dresden, Germany

View Trial Details